# Bioventus Inc.: Form 8-K, filed Jan 19, 2024

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2024-01-19
- Accepted by EDGAR: Jan 19, 2024, 08:27 ET
- Period: 2024-01-18
- Accession: 0001193125-24-010779
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000119312524010779/d709819d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000119312524010779/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000119312524010779/d709819d8k.htm

Filed Jan 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-010779. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.